Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Planning for Outcomes (P4O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix.

Lebetkin E, Gao X, Taylor D, Maldonado LY, Saad A, Steiner MJ, Dorflinger LJ, Nanda K, Mastro TD.

Glob Health Sci Pract. 2019 Jun 27;7(2):317-328. doi: 10.9745/GHSP-D-19-00062. Print 2019 Jun.

2.

HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995-2012.

Martin M, Vanichseni S, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Pitisuttithum P, Kaewkungwal J, van Griensven F, McNicholl JM, Tappero JW, Mastro TD, Kittimunkong S, Choopanya K.

EClinicalMedicine. 2019 Apr 1;9:44-51. doi: 10.1016/j.eclinm.2019.03.012. eCollection 2019 Mar.

3.

Assays for estimating HIV incidence: updated global market assessment and estimated economic value.

Morrison CS, Homan R, Mack N, Seepolmuang P, Averill M, Taylor J, Osborn J, Dailey P, Parkin N, Ongarello S, Mastro TD.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25018.

4.

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Auld AF, Shiraishi RW, Oboho I, Ross C, Bateganya M, Pelletier V, Dee J, Francois K, Duval N, Antoine M, Delcher C, Desforges G, Griswold M, Domercant JW, Joseph N, Deyde V, Desir Y, Van Onacker JD, Robin E, Chun H, Zulu I, Pathmanathan I, Dokubo EK, Lloyd S, Pati R, Kaplan J, Raizes E, Spira T, Mitruka K, Couto A, Gudo ES, Mbofana F, Briggs M, Alfredo C, Xavier C, Vergara A, Hamunime N, Agolory S, Mutandi G, Shoopala NN, Sawadogo S, Baughman AL, Bashorun A, Dalhatu I, Swaminathan M, Onotu D, Odafe S, Abiri OO, Debem HH, Tomlinson H, Okello V, Preko P, Ao T, Ryan C, Bicego G, Ehrenkranz P, Kamiru H, Nuwagaba-Biribonwoha H, Kwesigabo G, Ramadhani AA, Ng'wangu K, Swai P, Mfaume M, Gongo R, Carpenter D, Mastro TD, Hamilton C, Denison J, Wabwire-Mangen F, Koole O, Torpey K, Williams SG, Colebunders R, Kalamya JN, Namale A, Adler MR, Mugisa B, Gupta S, Tsui S, van Praag E, Nguyen DB, Lyss S, Le Y, Abdul-Quader AS, Do NT, Mulenga M, Hachizovu S, Mugurungi O, Barr BAT, Gonese E, Mutasa-Apollo T, Balachandra S, Behel S, Bingham T, Mackellar D, Lowrance D, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2017 Jun 2;66(21):558-563. doi: 10.15585/mmwr.mm6621a3.

5.

Determining the Incidence of Hepatitis C Virus Infection in Populations: An Important Tool for Epidemic Control.

Mastro TD, Morrison CS, Hamilton CD.

J Infect Dis. 2016 Aug 1;214(3):339-40. doi: 10.1093/infdis/jiw006. Epub 2016 Jan 14. No abstract available.

PMID:
26768254
6.

Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013.

Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F; MSAE, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1281-6. doi: 10.15585/mmwr.mm6446a2.

7.

The evolving HIV epidemic among people who inject drugs in India and the need for a heightened response.

Mastro TD, George B, Osborne K.

AIDS. 2015 Mar 13;29(5):629-31. doi: 10.1097/QAD.0000000000000593. No abstract available.

PMID:
25710289
8.

ARV-based HIV prevention for women - where we are in 2014.

Mastro TD, Sista N, Abdool-Karim Q.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19154. doi: 10.7448/IAS.17.3.19154. eCollection 2014. Review.

9.

PrEP in the real world.

Mastro TD.

Posit Aware. 2013 Summer;25(5):8-9. No abstract available.

PMID:
25358199
10.

Determining HIV incidence in populations: moving in the right direction.

Mastro TD.

J Infect Dis. 2013 Jan 15;207(2):204-6. doi: 10.1093/infdis/jis661. Epub 2012 Nov 5. No abstract available.

PMID:
23129757
11.

Managing depression in countries with low and middle incomes: an imperative for human immunodeficiency virus/acquired immune deficiency syndrome care and treatment and general public health.

van Dam CJ, Baumgartner JN, Mastro TD.

Psychosom Med. 2012 Nov-Dec;74(9):880-1. doi: 10.1097/PSY.0b013e318278eeef. Epub 2012 Nov 1. No abstract available.

PMID:
23118368
12.

Preexposure prophylaxis for HIV infection among African women.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, Temu L, Monedi MC, Mak'Oketch P, Makanda M, Reblin I, Makatu SE, Saylor L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D; FEM-PrEP Study Group.

N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.

13.

Youth and HIV: the intersection of homelessness, orphaned status, injection drug use and sexual risk.

Mastro TD, Cunningham J, Medrano T, van Dam J.

AIDS. 2012 Jan 2;26(1):111-3. doi: 10.1097/QAD.0b013e32834dcfa0. No abstract available.

PMID:
22126814
14.

Antiretrovirals for safer conception for HIV-negative women and their HIV-1-infected male partners: how safe and how available?

Mastro TD, Cohen MS, Rees H.

AIDS. 2011 Oct 23;25(16):2049-51. doi: 10.1097/QAD.0b013e32834c4c62. No abstract available.

PMID:
21997491
15.

HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043).

Piwowar-Manning E, Fiamma A, Laeyendecker O, Kulich M, Donnell D, Szekeres G, Robins-Morris L, Mullis CE, Vallari A, Hackett J Jr, Mastro TD, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Sweat M, Coates T, Eshleman SH.

BMC Infect Dis. 2011 Sep 24;11:251. doi: 10.1186/1471-2334-11-251.

16.

Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, Rousseau C, Rehle TM, Welte A, Averill MD, Garcia Calleja JM; WHO Working Group on HIV Incidence Assays.

AIDS. 2010 Nov 27;24(18):2763-71. doi: 10.1097/QAD.0b013e32833f1142. Review. No abstract available.

PMID:
20975514
17.

Honing the test-and-treat HIV strategy.

Mastro TD, Cohen MS.

Science. 2010 May 21;328(5981):976. doi: 10.1126/science.328.5981.976. No abstract available.

PMID:
20489007
18.

Male circumcision in the United States for the prevention of HIV infection and other adverse health outcomes: report from a CDC consultation.

Smith DK, Taylor A, Kilmarx PH, Sullivan P, Warner L, Kamb M, Bock N, Kohmescher B, Mastro TD.

Public Health Rep. 2010 Jan-Feb;125 Suppl 1:72-82. Erratum in: Public Health Rep. 2010 Jul-Aug;125(4):517.

19.

Addressing research priorities for prevention of HIV infection in the United States.

Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, El-Sadr WM.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S149-55. doi: 10.1086/651485. Review.

20.

Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.

Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia-Calleja JM.

J HIV AIDS Surveill Epidemiol. 2010 Jan 1;2(1):1-14.

21.

The power of HIV/AIDS epidemiology.

Mastro TD, Abdool Karim Q.

Curr Opin HIV AIDS. 2009 Jul;4(4):237-9. doi: 10.1097/COH.0b013e32832c92ac. No abstract available.

PMID:
19532058
22.

Epidemiology of HIV in the United States and Canada: current status and ongoing challenges.

Hall HI, Geduld J, Boulos D, Rhodes P, An Q, Mastro TD, Janssen RS, Archibald CP.

J Acquir Immune Defic Syndr. 2009 May 1;51 Suppl 1:S13-20. doi: 10.1097/QAI.0b013e3181a2639e.

PMID:
19384096
23.

Blood and seminal plasma HIV-1 RNA levels among HIV-1-infected injecting drug users participating in the AIDSVAX B/E efficacy trial in Bangkok, Thailand.

Kittikraisak W, van Griensven F, Martin M, McNicholl J, Gilbert PB, Chuachoowong R, Vanichseni S, Sutthent R, Tappero JW, Mastro TD, Hu DJ, Gurwith M, Kitayaporn D, Sangkum U, Choopanya K.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):601-8. doi: 10.1097/QAI.0b013e3181a44700.

24.

Universal voluntary HIV testing and immediate antiretroviral therapy.

Cohen MS, Mastro TD, Cates W Jr.

Lancet. 2009 Mar 28;373(9669):1077; author reply 1080-1. doi: 10.1016/S0140-6736(09)60640-1. No abstract available.

PMID:
19328992
25.

Advancing HIV prevention demonstration projects: new strategies for a changing epidemic.

Heffelfinger JD, Sullivan PS, Branson BM, Mastro TD, Purcell DW, Griffiths SD, Romaguera RA, Janssen RS.

Public Health Rep. 2008 Nov-Dec;123 Suppl 3:5-15. No abstract available.

26.

Using respondent-driven sampling for behavioural surveillance: response to Scott.

Lansky A, Mastro TD.

Int J Drug Policy. 2008 Jun;19(3):241-3; discussion 246-7. doi: 10.1016/j.drugpo.2008.03.004. Epub 2008 Apr 24. No abstract available.

PMID:
18439811
27.

Male circumcision for prevention of HIV transmission: what the new data mean for HIV prevention in the United States.

Sullivan PS, Kilmarx PH, Peterman TA, Taylor AW, Nakashima AK, Kamb ML, Warner L, Mastro TD.

PLoS Med. 2007 Jul 24;4(7):e223. No abstract available.

28.

HIV communication between husbands and wives: effects on husband HIV testing in northern Thailand.

Manopaiboon C, Kilmarx PH, Supawitkul S, Chaikummao S, Limpakarnjanarat K, Chantarojwong N, Xu F, van Griensven F, Mastro TD.

Southeast Asian J Trop Med Public Health. 2007 Mar;38(2):313-24.

PMID:
17539281
29.

Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.

Kilmarx PH, van de Wijgert JH, Chaikummao S, Jones HE, Limpakarnjanarat K, Friedland BA, Karon JM, Manopaiboon C, Srivirojana N, Yanpaisarn S, Supawitkul S, Young NL, Mock PA, Blanchard K, Mastro TD.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):327-34.

PMID:
16980907
30.

The legacy of unhygienic plasma collection in China.

Mastro TD, Yip R.

AIDS. 2006 Jun 26;20(10):1451-2. No abstract available.

PMID:
16791021
31.

HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial.

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, Mastro TD; VISION/VAX004 Study Team.

J Acquir Immune Defic Syndr. 2005 May 1;39(1):90-101.

PMID:
15851919
32.

Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand.

Hu DJ, Subbarao S, Vanichseni S, Mock PA, Ramos A, Nguyen L, Chaowanachan T, Griensven Fv, Choopanya K, Mastro TD, Tappero JW.

AIDS. 2005 Feb 18;19(3):303-8.

PMID:
15718841
33.

theta-Defensin pseudogenes in HIV-1-exposed, persistently seronegative female sex-workers from Thailand.

Yang C, Boone L, Nguyen TX, Rudolph D, Limpakarnjanarat K, Mastro TD, Tappero J, Cole AM, Lal RB.

Infect Genet Evol. 2005 Jan;5(1):11-5.

PMID:
15567134
34.

Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand.

Nguyen L, Chaowanachan T, Vanichseni S, McNicholl JM, Mock PA, Nelson R, Hodge TW, van Griensven F, Choopanya K, Mastro TD, Tappero JW, Hu DJ.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1318-23.

PMID:
15385741
35.

Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand.

Vanichseni S, Des Jarlais DC, Choopanya K, Mock PA, Kitayaporn D, Sangkhum U, Prasithiphol B, Hu DJ, van Griensven F, Mastro TD, Tappero JW.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1170-9.

PMID:
15319678
36.

Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials.

Buchacz K, Hu DJ, Vanichseni S, Mock PA, Chaowanachan T, Srisuwanvilai LO, Gvetadze R, Van Griensven F, Tappero JW, Kitayaporn D, Kaewkungwal J, Choopanya K, Mastro TD.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):853-60.

PMID:
15213570
37.

The prevalence of bisexual and homosexual orientation and related health risks among adolescents in northern Thailand.

van Griensven F, Kilmarx PH, Jeeyapant S, Manopaiboon C, Korattana S, Jenkins RA, Uthaivoravit W, Limpakarnjanarat K, Mastro TD.

Arch Sex Behav. 2004 Apr;33(2):137-47.

PMID:
15146146
38.
41.

Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.

Vanichseni S, Tappero JW, Pitisuttithum P, Kitayaporn D, Mastro TD, Vimutisunthorn E, van Griensvan F, Heyward WL, Francis DP, Choopanya K; Bangkok Vaccine Evaluation Group.

AIDS. 2004 Jan 23;18(2):311-6.

PMID:
15075550
42.

HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.

Hu DJ, Vanichseni S, Mock PA, Young NL, Dobbs T, Byers RH Jr, Choopanya K, van Griensven F, Kitayaporn D, McDougal JS, Tappero JW, Mastro TD, Parekh BS.

AIDS Res Hum Retroviruses. 2003 Sep;19(9):727-30.

PMID:
14585202
43.

New HIV type 1 CRF01_AE/B recombinants displaying unique distribution of breakpoints from incident infections among injecting drug users in Thailand.

Ramos A, Nguyen L, Hu DJ, Vanichseni S, Choopanya K, Young NL, Tappero JW, Mastro TD, Folks TM, Subbarao S.

AIDS Res Hum Retroviruses. 2003 Aug;19(8):667-74.

PMID:
13678469
44.

Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.

Yang C, Li M, Limpakarnjanarat K, Young NL, Hodge T, Butera ST, McNicholl JM, Mastro TD, Lal RB.

AIDS Res Hum Retroviruses. 2003 Aug;19(8):661-5.

PMID:
13678468
45.

Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.

Young CL, Hu DJ, Byers R, Vanichseni S, Young NL, Nelson R, Mock PA, Choopanya K, Janssen R, Mastro TD, Mei JV.

AIDS Res Hum Retroviruses. 2003 Jun;19(6):481-6.

PMID:
12882657
46.

Knowledge and perceptions of HIV among peripartum women and among men whose wives are of reproductive age, northern Thailand.

Tharawan K, Manopaiboon C, Ellertson CE, Limpakarnjanarat K, Kilmarx PH, Coggins C, Chaikummao S, Mastro TD, Elias CJ.

Contraception. 2003 Jul;68(1):47-53.

PMID:
12878287
47.

HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand.

Choopanya K, Des Jarlais DC, Vanichseni S, Mock PA, Kitayaporn D, Sangkhum U, Prasithiphol B, Hiranrus K, van Griensven F, Tappero JW, Mastro TD.

J Acquir Immune Defic Syndr. 2003 May 1;33(1):88-95.

PMID:
12792360
48.

Impact of enhanced notification of tuberculosis laboratory results to minimise treatment delay, Chiang Rai Hospital, Northern Thailand.

Uthaivoravit W, Yanai H, Tappero JW, Limpakarnjanarat K, Srismith R, Mastro TD, Mori T.

Int J Tuberc Lung Dis. 2003 Jan;7(1):46-51.

PMID:
12701834
49.

Risk of Mycobacterium tuberculosis infection and disease among health care workers, Chiang Rai, Thailand.

Yanai H, Limpakarnjanarat K, Uthaivoravit W, Mastro TD, Mori T, Tappero JW.

Int J Tuberc Lung Dis. 2003 Jan;7(1):36-45.

PMID:
12701833
50.

Risk factors for sexually transmitted diseases in northern Thai adolescents: an audio-computer-assisted self-interview with noninvasive specimen collection.

Paz-Bailey G, Kilmarx PH, Supawitkul S, Chaowanachan T, Jeeyapant S, Sternberg M, Markowitz L, Mastro TD, Van Griensven F.

Sex Transm Dis. 2003 Apr;30(4):320-6.

PMID:
12671552

Supplemental Content

Loading ...
Support Center